Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on the Safety and Effects of Inobrodib, Betamethasone Sodium Phosphate, and Dimethyl Fumarate in Patients with Advanced Blood and Bone Marrow Cancers

    Recruiting

    1 1 1 1
    Spain
  • Study on the Effectiveness of Lisaftoclax and Azacitidine in Adults with Newly Diagnosed Higher Risk Myelodysplastic Syndrome

    Recruiting

    3 1 1
    Investigated Drugs:
    Belgium Bulgaria Czechia Finland France Germany +7
  • Study on Ivosidenib for Patients with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome with IDH1 Mutation After Stem Cell Transplant

    Recruiting

    2 1 1 1
    Investigated Drugs:
    Germany
  • Study of Elritercept for Treating Anemia in Adults with Low to Intermediate Risk Myelodysplastic Syndromes

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Czechia France Germany Hungary Ireland +5
  • Study Comparing Treosulfan and Melphalan with Fludarabine for Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS) Undergoing Transplantation

    Recruiting

    2 1 1 1
    Germany
  • Study on Luspatercept for Treating Anemia in Patients with Myelodysplastic Syndromes (MDS) with del5q, Resistant to Prior Treatments and Needing Blood Transfusions

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy
  • Study on Ivosidenib and Azacitidine for Adults with Myelodysplastic Syndromes and IDH1 Mutation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Italy The Netherlands Spain
  • Study on the Safety and Effects of ION440 for Patients with MECP2 Duplication Syndrome

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria France Spain
  • Study of Azacitidine and Drug Combination Before Stem Cell Transplantation in Patients with High-Risk Myelodysplastic Syndrome

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Italy
  • Study of Elritercept for Treating Anemia in Patients with Low to Intermediate Risk Myelodysplastic Syndromes (MDS)

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia France Germany Spain